Literature DB >> 33034244

Ophthalmic findings and a novel CTC1 gene mutation in coats plus syndrome: a case report.

Tingyi Liang1, Xiang Zhang1, Yu Xu1, Peiquan Zhao1.   

Abstract

BACKGROUND: Coats plus syndrome is a rare multisystem disorder, and is also a telomere-related disorder caused by CTC1 gene mutation. We reported ophthalmic findings in a Chinese child with genetically confirmed Coats plus syndrome.
MATERIALS AND METHODS: The comprehensive ophthalmic findings were presented, as well as treatment history and systemic manifestations. In addition, genetic testing was performed to confirm the diagnosis.
RESULTS: Examination under anesthesia showed notable retinal vasculopathy, including vascular tortuosity and dilation, abnormal vascular anastomosis, retinal telangiectasias and mild exudation, extensive peripheral avascularity, as well as the presence of retinal neovascularization. The patient developed vitreous hemorrhage and tractional retinal detachment, and then underwent vitrectomy. Meanwhile, the patient was noted to have growth retardation and leukoencephalopathy. Gene testing identified a compound heterozygous mutation in CTC1 gene: a novel splicing site mutation (c.33 + 1 G > T) and a deletion mutation (c.2954_2956del, p.C985del), which were inherited from his mother and father, respectively.
CONCLUSIONS: The present report expanded the genotype and phenotype spectrum of CTC1 gene associated with Coats plus syndrome.

Entities:  

Keywords:  CTC1 gene; Coats plus syndrome; retinal vasculopathy; telomere

Year:  2020        PMID: 33034244     DOI: 10.1080/13816810.2020.1827443

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  1 in total

1.  Retinal Features of Family Members With Familial Exudative Vitreoretinopathy Caused By Mutations in KIF11 Gene.

Authors:  Hiroyuki Kondo; Itsuka Matsushita; Tatsuo Nagata; Etsuko Fujihara; Katsuhiro Hosono; Eiichi Uchio; Yoshihiro Hotta; Shunji Kusaka
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.